Sensitive Detection of Therapeutic Efficacy with the ETDRS Diabetic Retinopathy Severity Scale
Jiameng Zhang, Erich C Strauss Early Clinical Development, Genentech, Inc, South San Francisco, CA, USACorrespondence: Jiameng ZhangGenentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USAEmail zhang.jiameng@gene.comBackground: The Early Treatment Diabetic Retinopathy Study Diabetic Retinopath...
Guardado en:
Autores principales: | Zhang J, Strauss EC |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a39cfecf0bea4b36b89950f1b257868b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Self-Reported Awareness of Retinopathy Severity in Diabetic Patients
por: Qaseem Y, et al.
Publicado: (2020) -
Self-Reported Awareness of Retinopathy Severity in Diabetic Patients [Erratum]
por: Qaseem Y, et al.
Publicado: (2020) -
Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections
por: Levin AM, et al.
Publicado: (2017) -
Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab
por: Shakarchi FI, et al.
Publicado: (2018) -
Predictors of Early Diabetic Retinopathy Regression with Ranibizumab in the RIDE and RISE Clinical Trials
por: Singer M, et al.
Publicado: (2020)